Stockscreener 앱 받기
0.8925
0.62%
-0.006
전일 마감가:
$0.8985
열려 있는:
$0.8986
하루 거래량:
661.86K
Relative Volume:
0.51
시가총액:
$88.05M
수익:
-
순이익/손실:
$-93.61M
주가수익비율:
-0.423
EPS:
-2.11
순현금흐름:
$-71.16M
1주 성능:
-5.01%
1개월 성능:
+12.42%
6개월 성능:
-0.81%
1년 성능:
-36.22%
1일 변동 폭
$0.88
$0.9079
1주일 범위
$0.8606
$0.977
52주 변동 폭
$0.561
$1.73
Immunic Inc Stock (IMUX) Company Profile
명칭
Immunic Inc
전화
(332) 255-9818
주소
1200 AVENUE OF THE AMERICAS, NEW YORK
IMUX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.8925 | 88.64M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.62 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.68 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
552.20 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
809.14 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.45 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-29 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-25 | 개시 | William Blair | Outperform |
| 2024-11-25 | 개시 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-27 | 개시 | B. Riley Securities | Buy |
| 2022-10-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2021-04-15 | 개시 | Aegis Capital | Buy |
| 2021-03-24 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-02 | 개시 | SVB Leerink | Outperform |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-08-07 | 재개 | ROTH Capital | Buy |
| 2020-07-20 | 개시 | BMO Capital Markets | Outperform |
| 2020-06-05 | 개시 | Wedbush | Outperform |
| 2020-05-11 | 개시 | H.C. Wainwright | Buy |
| 2020-03-25 | 개시 | ROTH Capital | Buy |
| 2019-07-11 | 개시 | Chardan Capital Markets | Buy |
모두보기
Immunic Inc 주식(IMUX)의 최신 뉴스
Price momentum metrics for Immunic Inc. explained2025 Price Targets & Free Verified High Yield Trade Plans - newser.com
Detecting price anomalies in Immunic Inc. with AIJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Will Immunic Inc. stock see PE expansionProfit Target & Verified Stock Trade Ideas - newser.com
Why Immunic Inc. stock could outperform in 2025Rate Hike & Safe Entry Point Alerts - newser.com
Immunic targeting mental and physical challenges facing MS patientsICYMI - Proactive financial news
Can Immunic Inc. recover in the next quarterEarnings Trend Report & Weekly High Conviction Ideas - newser.com
Immunic marks World Mental Health Day, highlighting the mental consequence for MS patients - Proactive financial news
Why Immunic Inc. (10VA) stock fits value portfolios2025 Support & Resistance & Long-Term Growth Stock Strategies - newser.com
Why Immunic Inc. (10VA) stock benefits from AI revolutionProduct Launch & Verified Momentum Stock Alerts - newser.com
Comparing Immunic Inc. in custom built stock radarsJuly 2025 News Drivers & Technical Analysis for Trade Confirmation - newser.com
Immunic (NASDAQ:IMUX) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Immunic Presents Promising Phase 2 Trial Results - MSN
Immunic receives notice of allowance for vidofludimus calcium patent - MSN
Applying chart zones and confluence areas to Immunic Inc.Market Performance Report & Free Fast Entry Momentum Trade Alerts - newser.com
Is Immunic Inc. (10VA) stock positioned for secular growthQuarterly Portfolio Report & Daily Volume Surge Signals - newser.com
Chart overlay techniques for tracking Immunic Inc.Profit Target & Risk Controlled Stock Alerts - newser.com
Risk adjusted return profile for Immunic Inc. analyzed2025 Pullback Review & Expert Curated Trade Ideas - newser.com
Using data tools to time your Immunic Inc. exitEarnings Recap Report & Fast Gain Stock Trading Tips - newser.com
Why Immunic Inc. stock is favored by top institutionsPortfolio Value Summary & Long-Term Growth Plans - newser.com
Using data models to predict Immunic Inc. stock movementGold Moves & Growth Focused Stock Pick Reports - newser.com
Is Immunic Inc. stock ready for a breakout2025 Major Catalysts & Weekly Sector Rotation Insights - newser.com
How to read the order book for Immunic Inc.Earnings Overview Summary & Weekly Sector Rotation Insights - newser.com
Can Immunic Inc. stock sustain institutional interestGDP Growth & Weekly Top Gainers Trade List - newser.com
Can momentum traders help lift Immunic Inc.Earnings Growth Report & Weekly Breakout Stock Alerts - newser.com
Positive Signs As Multiple Insiders Buy Immunic Stock - Yahoo Finance
Chardan Capital Estimates Immunic FY2026 Earnings - MarketBeat
What earnings revisions data tells us about Immunic Inc.Weekly Trend Summary & Comprehensive Market Scan Insights - newser.com
Immunic to Participate in Scientific and Investor Conferences in October - The Malaysian Reserve
EQS-News: Immunic to Participate in Scientific and Investor Conferences in October01.10.25News - Ariva
Immunic Inc (IMUX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Immunic Inc 주식 (IMUX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
| Rudick Richard Alan | Director |
Nov 12 '24 |
Buy |
1.15 |
87,300 |
100,369 |
87,300 |
1.10%
자본화:
|
볼륨(24시간):